Tag: Links

Role of health care in the 2026 election. Where does economics fall in terms of study reproducibility? COVID-19’s “cicada” variant is spreading Best practices for transparent reporting for group based trajectory models. What is “learned helplessness”?

How to communicate your health policy research. JP Morgan employees sue employer over health benefits. Are insurers’ promised preauthorization reforms becoming a reality? The secret to happiness? Let’s gooooo!

FDA reverses its decision and will now review the Moderna flu vaccine. Could Australia be a model for FDA reform? “Pharma signals it’s done negotiating” Giant viruses. Hairy ball theorem.

Expert opinions: Will MFN reduce US drug prices? Robots in maternity care. What drives company decisions on new medicine launches and UK investment? Incorporating dynamic pricing into HEOR models (dynamicpv) Tale of 2 value sets. How to handle the lows? Honesty. Integrity in journalism: Giannis edition.

Regulation and Theory of the Adjacent Possible. Alex Taborrok on Trump pharmaceutical plan. Double negotiation? IRA + MFN. Mass General Brigham will provide AI pre-visits. Are ‘mobile crisis’ teams in crisis?

Life science options for commercialization success. There were fewer births in China in 2025 than in 1776. The end of vaccine development? “Medicare Part D led to a slower increase in AMR-related inpatient discharges” Is mobility the missing quality measure?

ChatGPT introduces OpenAI for Healthcare. AI can make prescription renewals in Utah. AMA’s perspective of physicians role with AI. US Army’s use of AI to improve soldiers’ mental health. Claim the AI skill boost.

FDA Qualifies First AI Drug Development Tool in MASH. No impact of Medicaid on crime rates. “The life of an artist is…” Elasticity of disability insurance (DI) takeup to DI generosity: 1.26 Do it anyway.

The licensing racket. Meta is not a monopoly. KFF debate on drug pricing in the US.  Use of AI by pharmaceutical manufacturers. FDA and agentic AI.

Impact of scope of practice laws in anesthesia. Reforming PBMs. UK COVID response: “Too little, too late” Enforcement of network adequacy requirements in Medicare Advantage. Access to orphan drugs in Central and Eastern Europe.